Pale Fire Capital SE »

Prelude Therapeutics shares owned by Pale Fire Capital SE

Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by Pale Fire Capital SE from 13F filings

Historical chart of Pale Fire Capital SE investment in Prelude Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Prelude Therapeutics held by Pale Fire Capital SE consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prelude Therapeutics by Pale Fire Capital SE

Quarter filed Position value Share count Share price at filing
2023-09-30 $95k 31k 3.09

More positions owned by Pale Fire Capital SE

Shell Spon Ads (SHEL)
BP Sponsored Adr (BP)
Groupon Com New (GRPN)
Dole Ord Shs (DOLE)
International Seaways (INSW)
Scorpio Tankers SHS (STNG)
Noble Corp Ord Shs A (NE)
Teekay Tankers Cl A (TNK)
Navios Maritime Partners Com Unit Lpi (NMM)
Tsakos Energy Navigation SHS (TNP)
Talos Energy (TALO)
Vodafone Group Sponsored Adr (VOD)
Iac Com New (IAC)
Valaris Cl A (VAL)
Danaos Corporation SHS (DAC)

View all positions for Pale Fire Capital SE

Top funds holding Prelude Therapeutics

OrbiMed Advisors
Baker Bros. Advisors
Deerfield Management Company
Boxer Capital
BlackRock
Vanguard Group
T. Rowe Price Associates
Massachusetts Financial Services
Geode Capital Management
Sio Capital Management
Morgan Stanley
TD Asset Management
Charles Schwab Investment Management
Bridgeway Capital Management
Northern Trust

View all funds holding Prelude Therapeutics